Exhibit 23.2
CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
BioMarin Pharmaceutical Inc.:
We consent to the use of our reports dated March 7, 2006, with respect to the consolidated balance sheets of BioMarin Pharmaceutical Inc. and subsidiaries (the Company) as of December 31, 2005 and 2004, and the related consolidated statements of operations, changes in stockholders’ equity (deficit), and cash flows for each of the years in the three-year period ended December 31, 2005, and the related financial statement schedule, management’s assessment of the effectiveness of internal control over financial reporting as of December 31, 2005, and the effectiveness of internal control over financial reporting as of December 31, 2005, incorporated herein by reference.
Our report on the Company’s financial statements as described above was based on our audits and the report of other auditors.
/s/ KPMG LLP
San Francisco, California
August 25, 2006